Showing results (241-250 of 463) with videos related to
Sort By:
Pageof 47
RMD Open|February 10, 2026
Evaluation of serial cardiovascular magnetic resonance monitoring and immunosuppressive therapy in predicting outcomes in systemic sclerosisAïcha Kante, Sandra Mghaeith, Bertrand Dunogue, et al.Presse Medicale (Paris, France : 1983)|February 27, 2007
Radiological bone lesions in fibroblastic rheumatism; case reportFrédérique Réty, One A Tayebjee, Amélie Servettaz, et al.Arthritis and Rheumatism|April 29, 2008
A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitidesCorneliu Henegar, Christian Pagnoux, Xavier Puéchal, et al.Arthritis and Rheumatism|July 20, 2011
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survivalMarc Humbert, Azzedine Yaici, Pascal de Groote, et al.The Journal of Rheumatology|September 3, 2010
Limited value of temporal artery ultrasonography examinations for diagnosis of giant cell arteritis: analysis of 77 subjectsCarla Maldini, Caroline Dépinay-Dhellemmes, Thi T S Tra, et al.Journal of Autoimmunity|April 20, 2024
Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosisKevin Chevalier, Guillaume Chassagnon, Sarah Leonard-Louis, et al.Journal of Autoimmunity|April 15, 2005
Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosisYouri Chanseaud, Mathieu C Tamby, Philippe Guilpain, et al.Seminars in Arthritis and Rheumatism|May 23, 2024
Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor studySara Boukhlal, Laurent Chouchana, Malika Saadi, et al.Arthritis and Rheumatism|February 2, 2008
Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patientsCamillo Ribi, Pascal Cohen, Christian Pagnoux, et al.Arthritis and Rheumatism|June 30, 2007
Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitisPhilippe Guilpain, Amélie Servettaz, Claire Goulvestre, et al.Pageof 47